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A reproducible method 
for biochemical, 
histological and functional 
assessment of the effects 
of ischaemia–reperfusion syndrome 
in the lower limbs
Iñigo Cearra 1,2,3, Borja Herrero de la Parte 2,3*, Diana Isabel Moreno‑Franco4 & 
Ignacio García‑Alonso2,3
Current methodology described to mimic lower limb ischaemia–reperfusion injury (LL‑IRI) does not 
accurately define the procedures and pressures exerted to induce and maintain ischaemia. In this piece 
of work, we propose a well‑defined and detailed rat model that simulates the conditions established 
in clinical practice guidelines for tourniquet application and allows us to test treatments that aim to 
prevent/reduce LL‑IRI. Eighty‑six male WAG/RijHsd rats were subjected to hind limb IRI (LL‑IRI), using 
a mechanical system applying a 1 kg tension to induce and maintain ischemia for 2 or 3 h, and assessed 
the damage caused by reperfusion at biochemical and muscular levels at different time points. At the 
biochemical level, both 2 and 3 h of ischemia induced changes (except for electrolyte levels); 3 h of 
ischemia induced greater changes in specific markers of muscular damage: creatine kinase (CK) and 
lactate dehydrogenase (LDH). At the histopathological level, 3 h of ischemia and 24 h of reperfusion 
was associated with an increase in hind limb girth, cross‑sectional area, and weight and presence of 
neutrophils, as well as histological damage in more than 60% of muscle fibres. Our model allows to 
reliably reproduce the damage associated with the use of a pneumatic tourniquet. CK and LDH, as 
well as measures of tissue damage, allow to define and characterize the response to LL‑IRI‑related 
damage. A period of 3 h of ischemia followed by 3 h of reperfusion caused only local damage but 
showed greater sensitivity to detect differences in future studies on prophylactic treatments against 
LL‑IRI.
Tourniquet-induced ischemia lasting for 1–2 h, or exceptional cases as long as 3 h, commonly achieved using a 
pneumatic cuff, is currently a routine process in extremity surgery, especially in orthopaedic surgery, allowing to 
obtain a bloodless surgical field, which facilitates surgical manoeuvres. However, its use entails a local ischemia/
reperfusion injury (IRI). IRI has been widely described and studied in numerous sites and tissue types. Briefly, 
it is a systemic immune response, triggered by the release of proinflammatory mediators and reactive oxygen 
species during reperfusion of an organ or tissue that has undergone some period of ischaemia. This damage, due 
to immune activation during reperfusion, is actually greater than that caused by the ischemia  itself1,2.
The clinical use of tourniquet cuffs has been associated with increased postoperative pain up to 2–6  weeks3,4. 
Further, greater swelling has been observed at  25 and  66weeks after surgery when tourniquet cuffs were used. 
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Moreover, from a functional point of view, significantly poorer range of motion (ROM), and greater postoperative 
weakness of the quadriceps several weeks after the tourniquet was applied have been  described4–8.
Several animal models of lower limb Ischaemia–reperfusion injury (LL-IRI) have been described to con-
duct experimental studies on these issues. However, there is poor consensus among them, both in terms of the 
animal model, the methodology employed, and the detailed description of the methodology, referring to them 
as "previously described by other authors". Literature on techniques for inducing LL-IRI includes invasive sur-
gical procedures, involving muscle disinsertion and surgical excision or clamping of the femoral  vessels9,10, to 
tourniquet models based on the application of a non-loosening nylon cable  tie11, or rubber or latex  bands12–19, 
used either in rats or mice. Both elastic tourniquets and high pressure levels applied with a uncontrolled tension 
tourniquet, such as rubber ring, increase both the frequency and severity of tourniquet-induced local  injuries20,21. 
Among these animal models, only those models described by  Bonheur18 and  Drysch19 apply a model that is 
similar to that used in clinical practice, which uses the minimal limb occlusion pressure (MLOP), defined as 
the pressure in the tourniquet at which the distal arterial blood flow, as assessed by a Doppler probe held over 
a distal artery, is occluded.
An additional point of contention is whether ischaemia is performed on one (unilateral) or both (bilateral) 
limbs at the same time. Since, in the clinical settings, bilateral knee surgery might carry higher rates of blood 
transfusion, postoperative complications, increased incidence of 90-day mortality, venous or pulmonary throm-
boembolism and neurological  complications22–24, it seems that bilateral models might further increase damages, 
masking the effects of the LL-IRI itself.
In preclinical research, imprecise description of some crucial aspects for the experiments, such as 
proper methodological description and specification of all the parameters, is a major obstacle to ensure its 
 reproducibility25. Recently, in 2019, Sansa urged researchers to be more explicit and to publish ever more detailed 
experimental protocols, which allow others to repeat experiments. Moreover, he concluded that this "reproduc-
ibility crisis" could eventually undermine the general public’s confidence in biomedical research, which might 
entail other unfortunate  consequences26.
With that background, this piece of work details an experimental model in rats, based on several aspects of 
those already described by other authors, but closer to clinical practice, using a controlled tension system, as well 
as techniques and times similar to those employed in clinical practice. To quantify the LL-IRI, we have chosen 
those biochemical and histopathological parameters most related to the clinical use, among the many described 
in the scientific literature, and we have studied the best time of reperfusion to assess them. Additionally, we have 
also carried out physical studies to assess the degree of functional recovery after controlled ischaemia.
Results
Validation of the ischemia‑inducing system. All the procedures were well-tolerated, and no adverse 
events were reported. After applying an increasing tensile force ranging from 0.5 to 1 kg (with 0.1 kg incre-
ments), we found that it was necessary to apply 1 kg to achieve and maintain ischemia in 100% of the animals 
(Fig. 1A). These findings were confirmed both by the clinical signs described, but also by laser Doppler flow 
measurement (Fig. 1B).
Biochemical assessment of LL‑IRI. The results concerning the biochemical parameters studied are pre-
sented in Table 1 and Fig. 2. In general, it can be seen that the greatest damage was seen in animals subjected to 
3 h of ischemia, followed by 3 h of reperfusion.
Regardless of the duration of ischemia and subsequent reperfusion, the levels of electrolytes analysed  (Na+, 
 K+ and  Cl−) did not vary significantly from reference values (Fig. 2A–C; Table 1). The ischemia/reperfusion 
process led to an increase in urea and creatinine levels, the indicators of kidney function (Table 1). In the case 
of urea, a progressive increase was observed throughout the reperfusion process, with a peak after 3 h, with 
both durations of ischemia (2 h: 65 ± 9.9 mg/dL; 3 h: 68 ± 3.6 mg/dL); reaching 2.3-fold higher than levels in 
controls (28 ± 3.2 mg/dL; p < 0.001). One hour more of ischemia did not produce significant a change in urea 
levels (Fig. 2D). In contrast, serum creatinine levels were higher in the animals exposed to a longer duration of 
ischemia (Fig. 2E; p < 0.05). Specifically, with 2 h of ischemia, the peak was reached after 10 min of reperfusion 
Figure 1.  Percentage of animals developing ischemia under different tensile forces (A). Measurement of flow in 
the pedis artery territory in animals subjected to ischemia at 1 kg of tensile force (B).
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(0.648 ± 0.19 vs 0.36 ± 0.065 mg/dL in controls; p < 0.05), the level staying high until 3 h, whereas after 3 h of 
ischemia, creatinine levels continued increasing until a peak of 0.88 ± 0.31 mg/dL at 3 h.
In our experiments, the ischemia/reperfusion was not associated with increases in ALP activity (Fig. 2F). 
In fact, there were no significant changes in the levels of this enzyme in the animals exposed to 3 h of ischemia, 
while in those exposed to 2 h of ischemia, levels decreased significantly during the reperfusion period.
Regarding other ubiquitous enzymes, levels of AST and ALT (Fig. 2G,H, Table 1) progressively increased until 
3 h; at this point, they started to decrease but did not reach normal levels by 6 h. Though the pattern was similar in 
the two enzymes, the peak was more dramatic in the case of AST (391.8 ± 72 IU/L) than ALT (90.33 ± 13.19 IU/L).
Levels of CK, a very specific serum marker of muscle damage, followed a very similar pattern to those of AST, 
with a threefold increase in the first 10 min of reperfusion and a peak at 3 h (Fig. 2I). At all times, the serum levels 
of this enzyme were significantly higher in animals exposed to 3 h of ischemia rather than 2 h (3-h exposure: 
9459 ± 1467 IU/L vs 2-h exposure: 6429 ± 2007 IU/L, p < 0.01). As in the case of AST, CK levels did not reach 
normal values after 6 h of reperfusion.
Lastly, LDH levels (Fig. 2J, Table 1) also behaved similarly, with levels increasing markedly after just 10 min of 
reperfusion, reaching levels significantly higher than in controls at this point (44.83 ± 18.81 IU/L), and peaking 
at 3 h (1395 ± 262.4 IU/L; p < 0.01). In animals subjected to 3 h of ischemia, serum levels of LDH were higher 
throughout follow-up and did not return to normal after 6 h of reperfusion.
Anatomopathological evaluation of LL‑IRI. Twenty-four hours after removal of the tourniquet, the 
mean upper-thigh girth of the leg exposed to ischemia/reperfusion was 59.5 ± 4.96 mm, 13% larger than that of 
the other leg (control, 52.25 ± 4.13 mm; p < 0.0001). This increase in girth translates to an estimated 30% increase 
in the cross-sectional area: 283.5 ± 46.71  mm2 vs 218.6 ± 34.50  mm2 in the control leg (p < 0.0001) (Fig. 3A). 
Regarding the weight of the gastrocnemius muscle, we observed a nearly 10% increase, with a mean muscle 
weight of 1.98 ± 0.19 g for the legs exposed to the ischemia vs 1.81 ± 0.14 g for the control legs (p < 0.0001).
In the microscopic assessment (Fig. 3B), in animals exposed to 3 h of ischemia and 24 h of reperfusion, we 
observed alterations compatible with IRI-related damage in 65.53 ± 6.86% of fibres in the gastrocnemius muscle. 
The mean PMN count was 55.28 ± 9.73 cells/field, corresponding to approximately 4.52 ×  104 cells/mm2.
Rotarod test. Figure 4 shows the results obtained with the rotarod test. Because of the effects of the anaes-
thesia used during the ischaemia period, the test could not be performed on the day of the ischaemia (day 0). 
One day after ischaemia (day + 1, 21.17 ± 7.25 s), a marked decrease in fall latency time was observed, compared 
to the control, obtained one day before ischaemia (day-1, 199.58 ± 14.75  s; p < 0.0001). Despite a progressive 
increase in the latency to fall time up to the 10th day (150.5 ± 19.54 s), highly significant differences could still 
be observed, compared to the pre-ischemia benchmark time. Nevertheless, these differences were no longer 
observed in the 14th day (186 ± 6.39 s), when the latency to fall time is already similar to the time recorded before 
the ischaemia.
Discussion
Although numerous LL-IRI-related experimental studies have been conducted, the experimental models 
described in the literature are notably different, there being no consensus on a standard model. The differences 
are evident in various characteristics of the models including the method of inducing and maintaining the 
ischemia and the parameters used to assess damage as well as when it is assessed. This diversity makes it very 
Table 1.  Results of biochemical analysis and levels of electrolytes in serum. Data are presented as the mean, 
the corresponding standard deviation (SD) and the p value from comparison with the reference value of the 
control group (first line), considering p values < 0.05 to be significant. ALP alkaline phosphatase, AST aspartate 
aminotransferase, ALT alanine aminotransferase, CK creatine kinase, LDH lactate dehydrogenase.
Group Na+ (mEq/L) K+ (mEq/L) Cl− (mEq/L) Urea (mg/dL)
Creatinine 
(mg/dL) ALP (U/L) AST (U/L) ALT (U/L) CK (U/L) LDH (U/L)
Control 146.7 ± 0.95 4 ± 0.45 103.7 ± 1.5 28 ± 3.2 0.36 ± 0.065 122 ± 5.06 51.43 ± 2.64 41.71 1.604 82.17 ± 9.41 44.83 ± 18.81
IR-1 143.0 ± 4.18 n.s 4.68 ± 0.29 n.s 99.8 ± 4.76 n.s 39.60 ± 5.36 p < 0.05
0.648 ± 0.19 
p < 0.05
91.60 ± 26.6 
p < 0.01
114.8 ± 45.94 
n.s 52.50 ± 2.77 n.s
3168 ± 1314 
p < 0.01
480 ± 199 
p < 0.01
IR-2 142.9 ± 3.02 n.s 4.68 ± 0.36 n.s 100.1 ± 3.62 n.s 43.86 ± 6.01 p < 0.01
0.539 ± 0.12 
p < 0.05
89.17 ± 26.7 
p < 0.0001
128.0 ± 21.44 
n.s 55.50 ± 0.55 n.s
4025 ± 629.7 
p < 0.001
515 ± 166 
p < 0.01
IR-3 144.5 ± 3.08 n.s 4.83 ± 0.64 n.s 99.5 ± 2.88 n.s 68.33 ± 3.61 p < 0.001
0.633 ± 0.20 
p < 0.05
107.0 ± 14.68 
n.s
321.5 ± 76.38 
p < 0.001
81.33 ± 10.26 
p < 0.0001
6429 ± 2007 
p < 0.0001
1015 ± 310.8 
p < 0.0001
IR-4 142.3 ± 2.93 n.s 4.5 ± 0.63 n.s 97.8 ± 3.96 n.s 64.29 ± 16.3 p < 0.001 0.428 ± 0.14 n.s
96.39 ± 36.44 
n.s
188.67 ± 104.0 
p < 0.001
73.67 ± 18.50 
p < 0.0001
3872 ± 1834 
p < 0.001
609 ± 250.8 
p < 0.001
IR-5 147.2 ± 1.92 n.s 4.38 ± 0.57 n.s 102.6 ± 1.52 n.s 43.0 ± 8.09 p < 0.05 0.64 ± 0.15 n.s
122.8 ± 17.77 
n.s
156.8 ± 70.33 
p < 0.05
67.20 ± 18.10 
n.s
4870 ± 1623 
p < 0.001
770.4 ± 376.4 
p < 0.01
IR-6 145.7 ± 2.29 n.s 4.59 ± 0.36 n.s 102.4 ± 3.1 n.s 50.0 ± 7.81 p < 0.001
0.80 ± 0.23 
p < 0.01
117.66 ± 11.91 
n.s
174.1 ± 69.43 
p < 0.01
66.86 ± 21.73 
n.s
6042 ± 2570 
p < 0.0001
844.0 ± 328.2 
p < 0.01
IR-7 142.7 ± 1.75 n.s 4.27 ± 0.37 n.s 99.3 ± 2.06 n.s 64.8 ± 9.91 p < 0.001
0.88 ± 0.31 
p < 0.001
122.5 ± 19.17 
n.s
391.8 ± 72.0 
p < 0.001
90.33 ± 13.19 
p < 0.001
9459 ± 1467 
p < 0.0001
1395 ± 262.4 
p < 0.0001
IR-8 144.3 ± 2.8 n.s 4.52 ± 0.17 n.s 101.7 ± 1.86 n.s 64.2 ± 15.8 p < 0.001 0.55 ± 0.17 n.s
127.16 ± 37.18 
n.s
307.5 ± 93.35 
p < 0.001
79.00 ± 26.1 
p < 0.01
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Figure 2.  Measurements of serum electrolytes and enzymes of animals exposed to 2 h (circles, solid line) or 3 h 
(triangles, dashed lines) of ischemia and different periods of reperfusion. Na + (A), K + (B), Cl− (C), urea (D), 
creatinine (E), ALP (F), AST (G), ALT (H), CK (I) and LDH (J). Units are milliequivalents per litre (mEq/L) 
for  Na+,  K+ and  Cl−, mg/dL for urea and creatinine, and international units per litre (U/L) for ALP, AST, ALT, 
CK, and LDH. The asterisks indicate statistically significant differences when comparing the two durations of 
ischemia (2 or 3 h) in each reperfusion period analysed; *(p < 0.05), **(p < 0.01). ALP alkaline phosphatase, AST 
aspartate aminotransferase, ALT alanine aminotransferase, CK creatine kinase, LDH lactate dehydrogenase.
5
Vol.:(0123456789)
Scientific Reports |        (2021) 11:19325  | https://doi.org/10.1038/s41598-021-98887-9
www.nature.com/scientificreports/
difficult to evaluate the validity and efficacy of treatments tested, and warrants research to identify a model that 
is reproducible and reliable, as well as easily transferable to clinical practice.
An important question is the choice of the experimental animal. Several considerations have led us to decide 
in favour of using rats for the research. First, they have more similarities to humans, both in the anatomy of the 
lower limb muscles having the same muscle  groups27,28, and in the tolerance of tissues to ischemia and their 
response at biochemical and histopathological  levels29–32. In fact, this is the most widely used animal model in the 
study of LL-IRI9–16. It is also a species that is easy to handle and has gentle behaviour and suitable size, facilitating 
preoperative management and husbandry. Finally, our research group has proven experience in the handling of 
this species for the study of IRI in other body  systems33–35.
A second important question for establishing a good IRI model is which type of device or procedure to use 
to induce and maintain the ischemia. Published studies have used very simple devices, based on a ring or tube, 
that do not allow measurement of the pressure being applied to maintain the ischemia, and in most cases, apply 
an excess pressure leading to muscle damage resulting from crushing (crush syndrome), distorting the assess-
ment of damage due to IRI and making the model unlike clinical  practice9–16,36. For this reason, one of the goals 
of this study was to develop and optimise a mechanical system that imitates the gold standard used in clinical 
practice, namely, a pneumatic cuff, with which we can induce ischemia using as little pressure possible, and 
thereby, minimise the damage resulting from the compression.
It is difficult, however, to place a pneumatic cuff on a rat´s leg. First of all, due to the small size of the cuff that 
would be  needed37,38. Further, the truncated cone shape of the leg makes it very difficult to avoid it moving once 
inflated. To avoid these problems, finally we opted for a system of tension cables, similar in concept to the con-
trolled tension tourniquet described by Bonheur in a murine  model18. In mice, 0.2 kg was sufficient to maintain 
Figure 3.  Upper-thigh girth and cross-sectional area of the legs exposed to 3 h of ischemia and 24 h of 
reperfusion (grey) and the other legs, used as healthy controls (white). Girth and cross-sectional area 
are expressed in millimetres (mm, left axis) and millimetres squared  (mm2, right axis), respectively (A). 
Representative histological section of a limb subjected to ischemia–reperfusion (the green asterisk indicates an 
undamaged muscle fibber and the black asterisk shows a muscle fibber damaged by ischemia–reperfusion. The 
extensive polymorphonuclear cell infiltrate (stained in blue) and oedema between the muscle fibbers (white 
space) are also seen) (B).
Figure 4.  Rotarod test. The data shows the mean and standard deviation in the fall time (expressed in seconds) 
of the animals subjected to 3 h of ischaemia period; ns (p > 0.05), ****(p < 0.0001).
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the ischemia; in the case of rats, we have found it necessary to use 1 kg to achieve a suitable level of ischemia. 
In a previous study of retinal ischemia–reperfusion39 conducted in WAG/RijHsd rats of similar sex, age, and 
weight to those used in the present study, we determined a mean arterial pressure (MAP) of 126 ± 4.6 mm Hg; 
in different mouse strains, the MAP ranged from 108 to 114 mm Hg 40. This difference in MAP does not seem to 
be enough reason to justify a fivefold increase in tensile strength necessary to induce the onset of ischemia in the 
animals. The most plausible explanation for this difference appears to be simply the difference in size between the 
two species, but might also be related to the thickness of the cable used. We also believe that the support arms, 
one to keep the cable stable and one to apply gentle traction to the end of the leg, are useful extra features of our 
design that allow us to ensure that there are no undesired movements or loss of ischemia.
A third key question is which parameters to use to assess the damage. Among those reported in the literature, 
we have opted for those which are closest to the parameters used in clinical practice.
A considerable number of clinical studies, mainly focused on assessing the use of anaesthetic drugs to control 
the damage due to reperfusion immediately after removing a tourniquet, consider the measurement of ischemia 
modified albumin (IMA), isoprostanes-isofurans and malondialdehyde (MDA)41–45. Nonetheless, we believe 
that the use of these parameters, as well as being expensive, is not easily transferrable to clinical practice. In 
contrast, both CK and LDH have been widely studied in experimental  studies11,14,46,47, are good indicators of 
rhabdomyolysis and are used in clinical  practice48–50. In line with these studies, we observed a sudden increase 
in the levels of both of these enzymes, from the onset of the reperfusion process. Further, their pattern is highly 
compatible with what Murata et al. described in their crush syndrome  model14. In our case, the levels of these 
two enzymes peaked after 3 h of reperfusion, while other  authors11 reported a peak after 4 h. To our mind, it is 
very interesting that, after a sudden increase immediately after the start of the reperfusion (observed at 10 min) 
and the levels remaining more or less stable until 60 min, there is a second increase by 3 h. We could speculate 
that the initial increase after just 10 min seems to be too early to be due to reperfusion. In fact in vitro studies 
show that skeletal and cardiac muscle fibbers submitted to anoxia release significant amount of LDH and  CK51,52.
The rest of the biochemical markers analysed (electrolytes, markers of kidney function and other nonspecific 
enzymes) have been studied by other authors in different models of lower limb  ischemia2,11,14. Findings with our 
model are fairly similar to their results, in terms of a lack of changes in electrolyte and ALP levels, and slight 
increases in AST and ALT levels after long periods of reperfusion.
Finally, the markers of kidney damage (urea and creatinine), widely used in IR models, show different pat-
terns. The increase in urea levels continues beyond the period of reperfusion studied, while creatinine increases 
early on, its levels returning to normal after 6 h.
We should also note that some studies in the literature mention the use of indicators of acid–base balance 
such as lactate, pH or the anion GAP. These tend to be considered, however, for assessing longer-lasting ischemia 
and higher compressive forces with potential systemic  complications14,53,54, and we have not measured them in 
our model, which only causes local damage.
Although ischemia does not tend to be induced for longer than 2 h in clinical practice, our observations 
indicate that with ischemia lasting 3 h, the damage remains local and reversible, as  expected30,32,55, although it is 
obviously increased. For this reason, we believe that 3 h is an ideal duration of ischemia for testing experimental 
treatments, providing the opportunity to observe any potential protective effects more clearly. In the case of 
biochemical analysis, based on our own experience and findings of other  studies11,14, we believe that measure-
ments should be made after 3 h of reperfusion.
Assessment of histopathological damage is the most controversial and a matter of debate in the literature. 
While it would be possible to measure substances such as myeloperoxidase, MDA or glutathione by spectropho-
tometry, this approach is not routinely used in hospitals, and hence, results would be difficult to translate to clini-
cal practice and to interpret, and additionally, the measurements are technically complicated and  expensive12,14,15. 
For this reason, we have again opted for parameters that are more commonly used in clinical practice, in particu-
lar, direct assessment of tissue swelling by measuring leg girth, which is easy to perform in patients.
In our model, the swelling present after 24 h of reperfusion increased the upper-thigh cross-sectional area by 
30%. This figure is similar to those from a rabbit experimental  model56, in which there was a 38% in the cross-
sectional area after 4 h of ischemia and 24 h of reperfusion. Regarding the weight of the gastrocnemius muscle, 
we observed a 10% increase, while  Bonheur18 reported a 22% increase, after 3 h of ischemia and 24 h of reper-
fusion. The difference may be due to Bonheur having used mice, which are a priori more fragile and sensitive.
Other parameters assessed in the literature include histological damage and leukocyte infiltration assessed 
by  microscopy14,17,18,36,56. Our results quantifying microscopic damage, expressed as the percentage of damaged 
fibres per field, in accordance with the method described by  McCormack36, indicate that two-thirds (66%) of 
fibres were damaged. This is in line with figures reported by other authors, who have found damage in up to 25% 
of fibres after 90  min17 and 80% after 4  h56 of ischemia. Finally, the PMN count obtained was 4.52 ×  104 cell/mm2, 
consistent with the findings of Deune et al. in a rabbit model with ischemia lasting for 4  h56.
Finally, it is of outmost importance that experimental models translate pathological and biochemical dam-
age into functional impairment or recovery, as this late aspect is what really matter in the clinical setting. In 
fact, several clinic studies in this field include postoperative mobility indexes or  scales6,57,58. Measuring physical 
activity of animals is not an easy task, but the Rotarod is an acceptably good  approximation59–62. In fact, we have 
been able to demonstrate an impairment due to ischemia–reperfusion, which is recovered after an acceptable 
period of time. This offers another parameter to assess utility of any proposed treatment.
Conclusions
The system for inducing and maintaining the ischemia designed for this study allows us to reliably simulate 
the damage associated with the use of a pneumatic cuff in clinical practice, especially in orthopaedic surgery.
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The biochemical parameters considered, in particular, CK and LDH levels, and measures of tissue damage 
(swelling, muscle fibre damage and PMN infiltration) have allowed us to define and characterise the LL-IRI-
related damage.
Our results enable us to establish a protocol based on 3 h of ischemia and 3 h of reperfusion as a model of 
LL-IRI which is representative of local damage, similar to that occurring in clinical practice; but lasting more 
than usual, is more sensitive, facilitating the detection of differences in future studies of prophylactic treatments 
against LL-IRI.
Materials and methods
All the procedures were carried out in accordance with current legislation and were approved by Experimental 
Animal Ethical Committee of the University of the Basque Country (ref.: M20/2015/075 HERRERO DE LA 
PARTE). The study was carried out in compliance with the ARRIVE guidelines.
For this study, we used 3- to 4-month-old male WAG/RijHsd rats, with a mean weight of 302 ± 12 g, bred 
and housed in the animal facilities at the University of the Basque Country (UPV/EHU). Animals were kept in 
groups of six in type IV cages (ref. 031,200,126, Harvard Apparatus) with wood shavings (F200017, Courbehaye, 
France) with food (SAFE A04 SP-10, SAFE Complete Care Competence, Augy, France) and water ad libitum, at 
a constant temperature of 24 °C under a 12-h:12-h light–dark cycle.
Experimental design. To minimize the influence of circadian variations on the results, all procedures to 
induce LL-IRI were carried out in the morning. In total, to develop the model and then characterise it, we used 
86 animals that were randomised to 11 experimental groups, as shown in Table 2. In all cases, the lower limb 
subjected to ischemia was the right hind limb.
As a first step, we determined the pressure required to produce and maintain ischemia. For this purpose, after 
exsanguination of the leg with a rubber bandage, the pressure group (PG) animals were subjected to increasingly 
higher pressures (0.5, 0.6, 0.7, 0.8, 0.9, 1 kg), until the appearance of clinical signs of ischemia (paleness, coldness) 
and confirmation of a lack of blood flow in the dorsalis pedis artery, with a Doppler laser probe.
Another group of six animals (the control group, CG) was used to determine both the baseline biochemical 
parameters and the normal histological structure of the gastrocnemius muscle in the lineage of animals used. The 
pathophysiological response to LL-IRI at the biochemical level was evaluated in ischemia/reperfusion groups 1 
to 8 (IR-1 to IR-8), with different durations of ischemia (2 and 3 h) and reperfusion (10, 60, 180 and 360 min). 
Finally, the ischemia/reperfusion group 9 (IR-9) allowed us to evaluate the consequences at the histopathological 
level of LL-IRI (after 3 h of ischemia and 24 h of reperfusion).
System for inducing and maintaining lower limb ischemia. We used a mechanical system developed 
in-house to induce and maintain ischemia. It includes an adjustable stand allowing the anaesthetized animal to 
be placed in a supine position. The tourniquet we used to produce the ischemia was made of a 2-mm diameter 
nylon cable and this was connected to a piston system and a dynamometer (Fig. 5), allowing adjustment of the 
pressure applied with the tourniquet to the desired level.
Table 2.  Experimental groups. Description of experimental groups and animals used in each group.
Group Purpose of the group Number of animals
Pressure Optimisation of pressure used to induce ischemia 20
Control Determination of baseline enzyme levels and normal histological structure 6
IR-1 Biochemical analysis after2 h of ischaemia and 10 min of reperfusion 6
IR-2 Biochemical analysis after2 h of ischaemia and 1 h of reperfusion 6
IR-3 Biochemical analysis after2 h of ischaemia and 3 h of reperfusion 6
IR-4 Biochemical analysis after2 h of ischaemia and 6 h of reperfusion 6
IR-5 Biochemical analysis after3 h of ischaemia and 10 min of reperfusion 6
IR-6 Biochemical analysis after3 h of ischaemia and 1 h of reperfusion 6
IR-7 Biochemical analysis after3 h of ischaemia and 3 h of reperfusion 6
IR-8 Biochemical analysis after3 h of ischaemia and 6 h of reperfusion 6
IR-9 Histopathological analysis after3 h of ischaemia and 24 h of reperfusion 6
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Anaesthesia and surgical procedure. Animals were anaesthetized using diazepam (15 mg/kg), keta-
mine (80 mg/kg) and medetomidine (0.5 mg/kg) and placed, supine, on the aforementioned stand. The cable 
connected to the dynamometer was fixed around the right hind limb, which was held up with a support arm. 
Once the leg was exsanguinated using a rubber bandage, like an Esmarch bandage (Fig. 6A), the piston was 
used to tighten the cable to obtain a dynamometer reading of 1 kg and thereby maintain ischemia in the leg 
(Fig. 6B)41. The conditions were confirmed to be truly ischemic by observing a lack of capillary refill and pale-
ness of the leg (Fig. 6C) and using a Doppler laser probe on the area of the dorsalis pedis artery. Halfway through 
the ischemia, diazepam was administered again (7.5 mg/kg) to keep the animal sedated until the end of the 
ischemia. After this time (2 or 3 h, depending on the experimental group), we released the pressure applied by 
the cable, allowing reperfusion in the leg for the period allocated in each experimental group. Restoration of 
blood flow was confirmed by the presence of clinical signs, in particular, the sudden onset of reactive hyper-
aemia. For post-ischemia recovery, the animals were placed in cages with wood shavings under a heat lamp at 
22–24 °C and checked every 30 min.
Blood sample collection and biochemical analysis. At the end of the reperfusion period, animals 
were placed in a supine position under inhalation anaesthesia with isoflurane at 1.5%. We performed wide 
laparotomy and evisceration to identify the inferior vena cava. Once identified, it was dissected, and using a 21G 
needle, punctured to collect as high a volume of circulating blood as possible (5–7 ml). These procedures imply 
the death of the animal, though this was ensured by cervical luxation.
The blood obtained was centrifuged at 3000 rpm for 10 min in II SST™ tubes (BD Vacutainer®, New Jersey, 
USA). The serum obtained was aliquoted and kept at − 25 °C until analysis.
All the biochemical parameters of interest were measured using a Cobas® 8000 c702 modular analyser (Roche 
Diagnostics GMBH, Mannheim, Germany). Specifically, we measured following: indicators of kidney function 
(urea and creatinine levels); levels of electrolytes, namely, sodium (Na +), potassium (K +) and chloride  (Cl−), 
Figure 5.  System designed for performing the ischemia. The leg is placed into the loop of the tourniquet 
(asterisk), adjusting the tensile force with the dynamometer (arrow). The tourniquet is fitted at the top of the 
thigh with the help of a support arm (lower arrowhead), while the other support arm (upper arrowhead) pulls 
on the end of the leg.
Figure 6.  Procedure for inducing ischemia. Exsanguination of the leg is performed with a rubber bandage 
(A), the tourniquet is fitted to the base of the leg and the bandage removed (B). It is confirmed that ischemia is 
maintained by the observation that the leg is pale (C).
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ubiquitous enzymes, namely, alkaline phosphatase (ALP), aspartate aminotransferase (AST) and alanine ami-
notransferase (ALT), and lastly muscle enzymes, namely, creatine kinase (CK) and lactate dehydrogenase (LDH).
Anatomopathological analysis. Tissue damage was assessed 24 h after the end of the ischemia, by meas-
uring the girth of both legs (experimental and control) and histological analysis of gastrocnemius muscle sec-
tions.
Specifically, to assess the swelling caused by LL-IRI, the hind leg girth was measured at the top of the thigh 
by wrapping a tape measure around the limb, while the animal was anaesthetized with isoflurane at 1.5%. To 
standardize the procedure, this measurement was taken after shaving the leg (with an electric shaver), and while 
the animal was on the stand of the ischemia-inducing system with gentle traction applied to the end of the leg 
using one of the system’s support arms. We measured upper-thigh girth in both experimental (IR) and control 
(paired control) legs.
After this, animals were sacrificed under anaesthesia by exsanguination through the abdominal aorta. After 
checking that animals were dead, the gastrocnemius muscles of both legs were removed, weighed and fixed in 
formaldehyde at 4%. At least 24 h later, specimens were embedded in paraffin, and subsequently, they were sliced 
into 3-µm histological sections which were stained with haematoxylin/eosin for histological analysis.
Tissue damage was assessed by counting the number of muscle fibres damaged with respect to the total 
number of fibres observed in five randomly selected  fields36. We also assessed polymorphonuclear neutrophil 
(PMN) infiltration, by counting the number of these cells in each field.
Rotarod test. Six rats were tested on a Rotarod apparatus (Panlab Hardvard Apparatus, Barcelona, Spain). 
The rats were placed on a moving rod with a rotation speed of 15 rpm. Following the 15 s acclimation time, the 
Rotarod was gradually accelerated on a 30-s slope, which increased the speed from 15 to 25 rpm.
Once the rod acceleration started, the latency to fall time started to be recorded automatically by the SeDa-
Com v2.0.03 software (Panlab Hardvard Apparatus, Barcelona, Spain); the speed of the rotarod at the time of 
fall was also recorded. Prior to ischemia induction, animals were subjected to a 2-day training protocol before 
being tested on the day -1, which acclimated the rats to the rotarod. The animals were subjected to the Rotarod 
test every day during the first week after ischemia, and also on day 10 and day 14.
Statistical analysis. The statistical analysis was carried out using Prism® 7 software (GraphPad Software, 
San Diego CA, USA). First, the Kolmogorov–Smirnov test was used to check the distribution of the data. Hav-
ing confirmed that data were normally distributed, the results were expressed as means and standard deviations 
(SDs), and between-group comparisons were performed with parametric tests.
Comparisons between legs subjected to ischemia/reperfusion and the controls were made using the Student’s 
t-test for paired samples, while comparisons between the different experimental groups were made using analysis 
of variance (ANOVA) and the Newman-Keuls post-hoc test. In all the analyses, p values < 0.05 were considered 
statistically significant.
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